NPM1 and breast cancer: Though ER−/PR−/HER-2− breast cancers are all defined as TNBCs, there are different biological behavior, clinical features, therapeutic response and driver genes among them, and the function of NPM1 in regulating PD-L1 expression may be related to the subtypes of TNBCs.